Sapu Nano
PrivateLast Round
Joint Venture
Apr 4, 2022
Est. Valuation
$50.18M
Company Overview
Sapu Nano is a biotechnology company developing the proprietary Deciparticle™ nanomedicine platform for the intravenous delivery of poorly water-soluble therapeutics, with a primary focus on oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sapu Nano Comparables
Compare Sapu Nano with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SciTech Development | 86% | |
| OncoNano Medicine | 83% | |
| Onselex Pharmaceuticals | 81% | |
Sapu Nano Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Joint Venture | Apr 4, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2022
$28M raised with Oncotelic Therapeutics, Inc.
Sapu Nano Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sapu Nano's valuation, stock price, and market status.